White Pine Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,145
| Closed | -$367K | – | 223 |
|
|
2018
Q3 | $367K | Hold |
2,145
| – | – | 0.13% | 170 |
|
|
2018
Q2 | $277K | Sell |
2,145
-8,648
| -80% | -$1.12M | 0.1% | 195 |
|
|
2018
Q1 | $1.11M | Sell |
10,793
-721
| -6% | -$74.3K | 0.41% | 69 |
|
|
2017
Q4 | $984K | Buy |
11,514
+40
| +0.3% | +$3.42K | 0.36% | 78 |
|
|
2017
Q3 | $975 | Sell |
11,474
-449
| -4% | -$38 | ﹤0.01% | 89 |
|
|
2017
Q2 | $903K | Sell |
11,923
-160
| -1% | -$12.1K | 0.36% | 86 |
|
|
2017
Q1 | $798K | Sell |
12,083
-20
| -0.2% | -$1.32K | 0.32% | 94 |
|
|
2016
Q4 | $767K | Hold |
12,103
| – | – | 0.33% | 91 |
|
|
2016
Q3 | $771K | Sell |
12,103
-1,042
| -8% | -$66.4K | 0.33% | 86 |
|
|
2016
Q2 | $978K | Sell |
13,145
-3,887
| -23% | -$289K | 0.41% | 65 |
|
|
2016
Q1 | $1.14M | Sell |
17,032
-288
| -2% | -$19.2K | 0.49% | 55 |
|
|
2015
Q4 | $1.17M | Sell |
17,320
-281
| -2% | -$19K | 0.52% | 49 |
|
|
2015
Q3 | $940K | Sell |
17,601
-761
| -4% | -$40.6K | 0.44% | 60 |
|
|
2015
Q2 | $1.16M | Sell |
18,362
-7,134
| -28% | -$449K | 0.5% | 55 |
|
|
2015
Q1 | $1.23M | Buy |
25,496
+1,403
| +6% | +$67.5K | 0.5% | 62 |
|
|
2014
Q4 | $800K | Buy |
24,093
+4,897
| +26% | +$163K | 0.27% | 108 |
|
|
2014
Q3 | $563K | Buy |
19,196
+11,141
| +138% | +$327K | 0.19% | 134 |
|
|
2014
Q2 | $313K | Hold |
8,055
| – | – | 0.11% | 176 |
|
|
2014
Q1 | $338K | Sell |
8,055
-14,507
| -64% | -$609K | 0.12% | 176 |
|
|
2013
Q4 | $740K | Sell |
22,562
-1,603
| -7% | -$52.6K | 0.26% | 104 |
|
|
2013
Q3 | $652K | Sell |
24,165
-3,206
| -12% | -$86.5K | 0.22% | 120 |
|
|
2013
Q2 | $639K | Buy |
+27,371
| New | +$639K | 0.22% | 118 |
|